文献速递腹部骨肌技术与安全CTMR

双层探测器光谱CT脂肪定量:实验开发与首次患者验证

Fat Quantification in Dual-Layer Detector Spectral Computed Tomography: Experimental Development and First In-Patient Validation.
PubMed 文献 · Invest Radiol · 2022-02-11

本研究为双层探测器光谱CT开发三物质分解脂肪定量算法,在体模中与MR化学位移弛豫测量和MR波谱对照,并前瞻性纳入10例需CT分期的患者验证肝脏和骨骼肌脂肪定量;体模和骨骼肌一致性优秀,肝脏(对数转换后)一致性中等,结论认为临床常规dlsCT可回顾性检测肝脂肪变性和肌脂肪变性。

要点

  • dlsCT脂肪定量在体模中与MR一致性优秀(ICC 0.98/0.96)。
  • 骨骼肌脂肪定量与MR一致性优秀(ICC 0.96)。
  • 肝脏脂肪定量(对数转换后)与MR一致性中等(ICC 0.75)。

核心结论

  • dlsCT脂肪定量算法在体模和患者肝脏、骨骼肌中与MR技术显示一致性,临床常规dlsCT扫描可回顾性检测肝脂肪变性和肌脂肪变性,且光谱信息独立于成像模式。

研究设计与样本

  • 可行性研究;体模含0%、5%、10%、25%、40%脂肪和0、4.9、7.0 mg/mL碘,用IQon光谱CT在120 kV和140 kV扫描,并与3 T MR化学位移弛豫测量和MR波谱对照;前瞻性纳入10例需CT分期的患者(平均年龄55±18岁,6例男性),行120 kV对比增强腹部dlsCT和MR化学位移弛豫测量,参考组织用回顾性可用的非增强光谱CT数据集。

诊断标准与关键数值

  • 体模dlsCT与MRR的ICC为0.98(95%CI 0.94-0.99),dlsCT与MRS的ICC为0.96(95%CI 0.87-0.99);骨骼肌ICC为0.96(95%CI 0.89-0.98);肝脏脂肪值经对数转换后ICC为0.75(95%CI 0.48-0.88);Bland-Altman分析肝脏平均差异-0.7%(95%CI -4.5至3.1),骨骼肌平均差异0.5%(95%CI -4.3至5.3);观察者间和观察者内一致性均>0.9。

临床应用与阅片要点

  • dlsCT扫描可回顾性提供光谱信息并用于肝脏和骨骼肌脂肪定量,报告时可参考与MR的一致性数据:体模和骨骼肌一致性优秀,肝脏(对数转换后)一致性中等。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Fat quantification by dual-energy computed tomography (DECT) provides contrast-independent objective results, for example, on hepatic steatosis or muscle quality as parameters of prognostic relevance. To date, fat quantification has only been developed and used for source-based DECT techniques as fast kVp-switching CT or dual-source CT, which require a prospective selection of the dual-energy imaging mode.It was the purpose of this study to develop a material decomposition algorithm for fat quantification in phantoms and validate it in vivo for patient liver and skeletal muscle using a dual-layer detector-based spectral CT (dlsCT), which automatically generates spectral information with every scan.

MATERIALS AND METHODS: For this feasibility study, phantoms were created with 0%, 5%, 10%, 25%, and 40% fat and 0, 4.9, and 7.0 mg/mL iodine, respectively. Phantom scans were performed with the IQon spectral CT (Philips, the Netherlands) at 120 kV and 140 kV and 3 T magnetic resonance (MR) (Philips, the Netherlands) chemical-shift relaxometry (MRR) and MR spectroscopy (MRS). Based on maps of the photoelectric effect and Compton scattering, 3-material decomposition was done for fat, iodine, and phantom material in the image space.After written consent, 10 patients (mean age, 55 ± 18 years; 6 men) in need of a CT staging were prospectively included. All patients received contrast-enhanced abdominal dlsCT scans at 120 kV and MR imaging scans for MRR. As reference tissue for the liver and the skeletal muscle, retrospectively available non-contrast-enhanced spectral CT data sets were used. Agreement between dlsCT and MR was evaluated for the phantoms, 3 hepatic and 2 muscular regions of interest per patient by intraclass correlation coefficients (ICCs) and Bland-Altman analyses.

RESULTS: The ICC was excellent in the phantoms for both 120 kV and 140 kV (dlsCT vs MRR 0.98 [95% confidence interval (CI), 0.94-0.99]; dlsCT vs MRS 0.96 [95% CI, 0.87-0.99]) and in the skeletal muscle (0.96 [95% CI, 0.89-0.98]). For log-transformed liver fat values, the ICC was moderate (0.75 [95% CI, 0.48-0.88]). Bland-Altman analysis yielded a mean difference of -0.7% (95% CI, -4.5 to 3.1) for the liver and of 0.5% (95% CI, -4.3 to 5.3) for the skeletal muscle. Interobserver and intraobserver agreement were excellent (>0.9).

CONCLUSIONS: Fat quantification was developed for dlsCT and agreement with MR techniques demonstrated for patient liver and muscle. Hepatic steatosis and myosteatosis can be detected in dlsCT scans from clinical routine, which retrospectively provide spectral information independent of the imaging mode.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Molwitz, Campbell, Yamamura, et al. Fat Quantification in Dual-Layer Detector Spectral Computed Tomography: Experimental Development and First In-Patient Validation. Invest Radiol. 2022. PMID: 35148536. doi:10.1097/RLI.0000000000000858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。